| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Insulin-like growth factor-I (IGF-I) is a potent stimulator of bone formation. Whether this growth factor also induces bone resorption has not been studied in detail. We used two organ culture systems to examine the direct effect of IGF-I on bone resorption. Fetal mouse radii/ulnae, containing mature osteoclasts, showed no response to IGF-I, indicating that osteoclastic activity is not influenced by IGF-I. Fetal mouse metacarpals/metatarsals, containing just osteoclast precursors and progenitors, showed an increase in resorption in response to IGF-I, indicating that IGF-I stimulates the formulation of osteoclast precursors/progenitors and thereby increases the number of osteoclasts.
Interleukin-6 (IL-6) has been hypothesized to be a mediator of bone resorptive agents such as parathyroid hormone (PTH). Both radii/ulnae and metacarpals/metatarsals reacted to IGF-I with an increase in IL-6 production. IL-6 production by UMR-106 osteogenic osteosarcoma cells was positively modulated by IGF-I, indicating that osteoblasts are likely to be the cells responsible for increased IL-6 production by the bones, and that IL-6 might be a mediatory of IGF-I-stimulated bone resorption.
Journal of Endocrinology (1992) 132, 433–438
This article has been cited by other articles:
|
|
 |
|
  T. Ueland GH/IGF-I and bone resorption in vivo and in vitro Eur. J. Endocrinol., March 1, 2005; 152(3): 327 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ueland, J. Bollerslev, A. Flyvbjerg, T. B. Hansen, N. Vahl, and L. Mosekilde Effects of 12 Months of GH Treatment on Cortical and Trabecular Bone Content of IGFs and OPG in Adults with Acquired GH Deficiency: A Double-Blind, Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2760 - 2763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Santhanagopal and S. J. Dixon Insulin-like growth factor I rapidly enhances acid efflux from osteoblastic cells Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E423 - E432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mora, P. Pitukcheewanont, J. C. Nelson, and V. Gilsanz Serum Levels of Insulin-Like Growth Factor I and the Density, Volume, and Cross-Sectional Area of Cortical Bone in Children J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2780 - 2783. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Okada and S. Murakami Cytokine Expression in Periodontal Health and Disease Critical Reviews in Oral Biology & Medicine, January 1, 1998; 9(3): 248 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Franchimont, V. Gangji, D. Durant, and E. Canalis Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts Endocrinology, December 1, 1997; 138(12): 5248 - 5255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
